Characterization of RhoC Expression in Benign and Malignant Breast Disease

This publication has 10 references indexed in Scilit:

• Persistent E-Cadherin Expression in Inflammatory Breast Cancer
  Laboratory Investigation, 2001
• RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
  2000
• Neuroendocrine expression in metastaticprostate cancer: Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression
  Human Pathology, 2000
• Truncation of the β-Catenin Binding Domain of E-cadherin Precedes Epithelial Apoptosis during Prostate and Mammary Involution
  Journal of Biological Chemistry, 2000
• A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.
  1999
• The p160 RhoA-Binding Kinase ROKα Is a Member of a Kinase Family and Is Involved in the Reorganization of the Cytoskeleton
  Molecular and Cellular Biology, 1996
• Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase)
  Science, 1996
• Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia
  Cell, 1995
• A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.
  Journal of Clinical Oncology, 1989
• A prognostic index in primary breast cancer
  British Journal of Cancer, 1982